Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance

Cell Death and Differentiation
S SchmidtR Kofler

Abstract

The ability of glucocorticoids (GC) to efficiently kill lymphoid cells has led to their inclusion in essentially all chemotherapy protocols for lymphoid malignancies. This review summarizes recent findings related to the molecular basis of GC-induced apoptosis and GC resistance, and discusses their potential clinical implications. Accumulating evidence suggests that GC may induce cell death via different pathways resulting in apoptotic or necrotic morphologies, depending on the availability/responsiveness of the apoptotic machinery. The former might result from regulation of typical apoptosis genes such as members of the Bcl-2 family, the latter from detrimental GC effects on essential cellular functions possibly perpetuated by GC receptor (GR) autoinduction. Although other possibilities exist, GC resistance might frequently result from defective GR expression, perhaps the most efficient means to target multiple antileukemic GC effects. Numerous novel drug combinations are currently being tested to prevent resistance and improve GC efficacy in the therapy of lymphoid malignancies.

References

Mar 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·E B ThompsonB H Johnson
Oct 6, 1995·Science·C M KnudsonS J Korsmeyer
Jan 1, 1995·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·M SoufiH M Westphal
Nov 27, 1996·International Journal of Cancer. Journal International Du Cancer·M HalaR Kofler
Jun 11, 1997·International Journal of Cancer. Journal International Du Cancer·G S SalomonsL A Smets
Sep 29, 1999·Advances in Experimental Medicine and Biology·E G HaarmanA J Veerman
Sep 29, 1999·Advances in Experimental Medicine and Biology·P S Gaynon, A L Carrel
Jun 3, 2000·Annual Review of Immunology·J D AshwellM S Vacchio
Aug 6, 2000·Cell and Tissue Research·M Gómez-AngelatsJ A Cidlowski
Nov 9, 2000·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·C A LonguiG P Chrousos
Dec 19, 2000·Biochemical and Biophysical Research Communications·S L Planey, G Litwack
Feb 15, 2001·Cell Death and Differentiation·S Matsuyama, J C Reed
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M TonkoR Kofler
May 15, 2001·Trends in Immunology·M JondalS Okret
Jun 9, 2001·The Journal of Biological Chemistry·P R Mittelstadt, J D Ashwell
Jun 13, 2001·Oncogene·P Herrlich
Jul 21, 2001·Molecular Endocrinology·M B BreslinW V Vedeckis

❮ Previous
Next ❯

Citations

Jul 21, 2006·Acta Neuropathologica·Caroline PietteManuel Deprez
Dec 11, 2008·Journal of Bone and Mineral Metabolism·Sun-Il YunYoon-Sok Chung
Dec 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ingrid HerrMarkus W Büchler
May 8, 2009·Apoptosis : an International Journal on Programmed Cell Death·Christian PlonerReinhard Kofler
Jan 15, 2011·Bulletin of Experimental Biology and Medicine·N V RyazantsevaA N Baikov
Feb 11, 2011·Current Infectious Disease Reports·Djillali Annane
Apr 2, 2011·Pathology Oncology Research : POR·Judit DobosAndrea Ladányi
Apr 2, 2011·Rejuvenation Research·Gergely TalaberJudit E Pongracz
Dec 11, 2008·Journal of the National Cancer Institute·Nicolas PottierMeyling H Cheok
Sep 6, 2011·Rheumatology·Simon C BiddieStafford L Lightman
Dec 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yicheng MaoNatarajan Muthusamy
Dec 25, 2008·Molecular Endocrinology·Suzanne E WardellDonald P McDonnell
Dec 3, 2010·Pharmacogenomics·Daphne Wei-Chen ChenJean-Marc Schwartz
Dec 10, 2009·Folia Histochemica Et Cytobiologica·Hashemitabar MahmoudAlbughobeish Naeim
Sep 6, 2012·International Journal of Molecular Sciences·Sarah T WilkinsonMargaret M Briehl
Jul 21, 2006·Asian Journal of Andrology·Qian Wang, Hui-Bao Gao
Sep 1, 2012·Case Reports in Neurological Medicine·Marcus D MazurDaniel W Fults
Feb 23, 2013·ISRN Hematology·Ronit Vogt Sionov
Jul 1, 2014·Cellular Immunology·Justin L EddyHerbert L Mathews
May 14, 2014·BioMed Research International·Amphun ChaiboonchoeKourosh Salehi-Ashtiani
Apr 6, 2011·Wiener klinische Wochenschrift·Bastian OpplReinhard Kofler

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis